Fidelity Investments
HUMA icon

Fidelity Investments’s Humacyte HUMA Stock Holding History

Fidelity Investments’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Sell
19,289
-9,273
-32% -$8.59K ﹤0.01% 4761
2026
Q1 		$17.3K Buy
28,562
+21,745
+319% +$22.6K ﹤0.01% 4573
2025
Q4 		$6.55K Sell
6,817
-1,226
-15% -$1.74K ﹤0.01% 4833
2025
Q3 		$14K Buy
8,043
+235
+3% +$460 ﹤0.01% 4504
2025
Q2 		$16.3K Buy
7,808
+4,567
+141% +$8.77K ﹤0.01% 4367
2025
Q1 		$5.53K Sell
3,241
-22,337
-87% -$83.9K ﹤0.01% 4671
2024
Q4 		$129K Sell
25,578
-68,809
-73% -$340K ﹤0.01% 3439
2024
Q3 		$513K Buy
94,387
+20,930
+28% +$138K ﹤0.01% 2840
2024
Q2 		$353K Buy
73,457
+71,494
+3,642% +$372K ﹤0.01% 2851
2024
Q1 		$6.11K Sell
1,963
-1
-0.1% -$3 ﹤0.01% 4445
2023
Q4 		$5.58K Sell
1,964
-679
-26% -$1.74K ﹤0.01% 4412
2023
Q3 		$7.74K Buy
2,643
+414
+19% +$1.37K ﹤0.01% 4203
2023
Q2 		$6.38K Sell
2,229
-1,064
-32% -$3.84K ﹤0.01% 4289
2023
Q1 		$10.2K Buy
3,293
+2,898
+734% +$8.24K ﹤0.01% 4120
2022
Q4 		$833 Buy
395
+15
+4% +$46 ﹤0.01% 4682
2022
Q3 		$1K Buy
380
+304
+400% +$1.17K ﹤0.01% 4680
2022
Q2 		$0 Buy
+76
New +$423 ﹤0.01% 5187

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fidelity Investments's HUMA Position: Q2 2026 in Review

Fidelity Investments reduced its Humacyte (HUMA) stake by 32% in Q2 2026, selling an estimated $8.59K and leaving 19,289 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4761.

Fidelity Investments first reported a position in HUMA in Q2 2022 and has held it in 17 quarters since. The position peaked at $513K in Q3 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Fidelity Investments held 19,289 shares of Humacyte worth $15.1K as of Q2 2026.
  • Fidelity Investments sold 9,273 Humacyte shares in Q2 2026, an estimated $8.59K.
  • Humacyte made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4761 holding.
  • Fidelity Investments first reported a position in Humacyte in Q2 2022 and has held it in 17 quarters since.
  • Fidelity Investments's Humacyte position peaked at $513K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.